Breaking News

James Alexander Corporation Becomes 100% Employee-Owned

The packaging solutions manufacturer has expanded its ESOP, giving employees full ownership of the company.

James Alexander Corporation (JAC), a manufacturer of innovative dispensing and packaging solutions, has transitioned to 100% employee ownership through its Employee Stock Ownership Plan (ESOP), effective immediately.

The transaction represents a natural evolution of a commitment to employees that began in 2011, when JAC founder and Chairwoman Francesca Fazzolari established the company’s ESOP, giving employees a 20% ownership stake.

“Fifty years ago, James Alexander was founded with a vision for creating something special,” said Fazzolari. “As we celebrate 50 years, I can think of no better way to begin the company’s next chapter than by putting its future entirely in the hands of the people who have helped build it.”

“Since we established the ESOP in 2011, I have watched our employees embrace the responsibility and opportunity that comes with ownership. Today, they are not simply part owners – they are the owners. I couldn’t be more proud of them or more confident in the future of James Alexander.”

When JAC became an ESOP company, Fazzolari described the decision as a way to provide employees with something greater than a traditional bonus and to create an additional retirement benefit. As the company grows, employees benefit from the value they help create.

Many JAC employees have dedicated decades to the company, with some employees having been part of the organization for more than 20 years. The transition to 100% employee ownership recognizes that history while giving employees an even greater stake in the company’s continued success.

“Reaching 50 years is an extraordinary achievement,” said Fazzolari. “But this isn’t about looking back. It’s about looking forward. The next 50 years belong to our employees, and I am excited to see what they will accomplish.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters